ImmUniverse

By looking into the common disease mechanisms of Ulcerative Colitis and Atopic Dermatitis, ImmUniverse aims at improving diagnostic and therapeutic options for patients living with both conditions. Through molecular profiling techniques, the consortium will identify signatures of biomarkers and mechanistic principles which reveal information on disease severity and progression enabling personalised therapy decisions for each patient at the right time.